MuSigmas

Strategic statistical solutions for drug discovery

We offer statistical planning and regulatory support for early- and late-phase clinical trials and observational studies, with expertise in Adaptive Designs including Bayesian Designs, as well as the application of machine learning for biomarker discoveries and diagnostic device development. In addition to design and analysis, we offer support in regulatory defence for clinical trial designs and protocols, and Data Monitoring Committee (DMC) related services. While we cover all therapeutic areas, we have extensive experience in oncology, CVD, CNS, rare diseases, vaccine trials and medical devices. We are also actively involved in developing cutting-edge statistical tools and software to empower statisticians, data scientists and clinicians.

Planning for a clinical trial? Mitigate trial risk and increase efficiency with robust statistical planning — partner with us.